Johnson & Johnson preps for first CAR-T launch with a new patient support program, a dedicated sales team and more
Johnson & Johnson and partner Legend Biotech are expecting an FDA decision for their first CAR-T product, cilta-cel, in November. To prepare for the upcoming launch of the personalized cell therapy, the Big Pharma company is planning a specialized patient support program.
Source: fiercepharma.com